AI assistant
Sanofi — Director's Dealing 2010
Feb 12, 2010
1643_dirs_2010-02-11_b26659b6-0a39-49cb-b2af-97e88a6d9024.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CHATTEM INC (CHTT)
CIK: 0000019520
Period of Report: 2010-02-09
Reporting Person: SANOFI-AVENTIS (10% Owner)
Reporting Person: River Acquisition Corp. (10% Owner)
Reporting Person: Sanofi-Aventis Amerique du Nord S.N.C. (10% Owner)
Reporting Person: AVENTIS INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-09 | Common Stock, without par value | P | 28864905 | $93.50 | Acquired | 44622694 | Indirect |
| 2010-02-09 | Common Stock, without par value | P | 552321 | $93.50 | Acquired | 45175015 | Indirect |
| 2010-02-10 | Common Stock, without par value | P | 300936 | $93.50 | Acquired | 45475951 | Indirect |
| 2010-02-11 | Common Stock, without par value | P | 923268 | $93.50 | Acquired | 46399219 | Indirect |
Footnotes
F1: Reflects shares acquired by Aventis Inc. ("Aventis") from Chattem, Inc. ("Chattem"), pursuant to the exercise of the "top-up" option provided for in the Agreement and Plan of Merger, dated as of December 20, 2009, among sanofi-aventis ("Parent"), River Acquisition Corp. (the "Purchaser") and Chattem, and subsequently contributed to the Purchaser.
F2: The shares are held by the Purchaser. The Purchaser is an indirect, wholly-owned subsidiary of Parent and a direct, wholly-owned subsidiary of Aventis. Aventis is a wholly-owned subsidiary of Sanofi-aventis Am??rique du Nord S.N.C. ("ADN"). ADN is a wholly-owned subsidiary of Parent. The shares may also be deemed to be indirectly beneficially owned by Parent, ADN and Aventis.
F3: Reflects shares purchased in a tender offer.